This invention relates to a method of treating a disorder selected from
OCD, agoraphobia, agoraphobia without history of panic disorder, specific
phobia, social phobia, PTSD, restless legs syndrome, premenstrual
dysphoric disorder, hot flashes, and fibromyalgia by administering a
compound of the formula 1 ##STR00001## or a pharmaceutically acceptable
salt thereof, wherein:R.sup.1 is hydrogen, straight or branched alkyl of
from 1 to 6 carbon atoms or phenyl; andR.sup.2 is straight or branched
alkyl of from 4 to 8 carbon atoms, straight or branched alkenyl of from 2
to 8 carbon atoms, cycloalkyl of from 3 to 7 carbon atoms, alkoxy of from
1 to 6 carbon atoms, -alkylcycloalkyl, -alkylalkoxy, -alkyl OH,
-alkylphenyl, -alkylphenoxy, or -substituted phenyl. The invention also
relates to a method of treating the above disorders by administering the
compound (3S,5R)-3-Aminomethyl-5-methyl-octanoic acid.